Patient asks which product will be used: how to respond
"Which product are you going to use?" The question seems simple, but it carries a lot: curiosity, fear of a counterfeit product, the influence of a friend who "only uses brand X," and sometimes a distrust that was never voiced. Answering well is a chance to convey safety and transparency. Answering badly, with evasions or promises, opens the door to distrust. This page shows how to answer, what to show and what to record.
Why does the patient ask?
It is rarely just technical information.
- Fear of a fake or untraceable product, amplified today by the news.
- Influence from others: someone spoke well or badly of a brand.
- Price comparison: they want to understand why yours is different.
- A bad earlier experience, with another professional or product.
- A desire for control: they want to take part in the decision.
Before answering, ask: "What made you think about that?" It shows what lies behind it.
What is the patient entitled to know?
The patient may know what will be injected or implanted. That includes the type of product (hyaluronic acid, toxin, biostimulator), the name, the manufacturer, the ANVISA registration (Brazil's health regulatory agency), the batch and the expiration date. They are part of transparency and informed consent. For the concept of the most-used material, see hyaluronic acid.
| Information | What it is for the patient |
|---|---|
| Type and purpose of the product | Understand what will be done |
| Brand name and manufacturer | Research, compare, record |
| ANVISA registration | Check lawful provenance |
| Batch and expiration date | Traceability and safety |
| Amount used (ml or units) | Transparency of the plan |
| Area of application | Record and follow-up |
The practical rule: whatever you record in the patient record, the patient may know. See explaining hyaluronic acid to the patient, explaining botulinum toxin to the patient and explaining the biostimulator to the patient.
How to answer in four steps?
Opening the package in front of the patient is a simple practice that builds a lot of trust. When appropriate, show the label and the seal. For the same logic of transparency about who treats them, see who will perform it.
What about brand disputes?
The patient may arrive with a preference: "I only accept brand X." Or may compare: "So-and-so used that one and it looked great." The care here is not to turn the conversation into a commercial debate.
- Acknowledge the preference, without rebutting it right away.
- Explain the technical criteria. What matters is the indication, the area, how the product behaves, safety and your experience.
- Avoid criticizing other brands. It is enough to say what you use and why.
- Be honest if the patient's preference is not suitable for the case.
- Do not promise that the product "lasts longer" or "gives a better result."
The Harmy website and pages do not recommend brands, and neither does this one: the point here is the posture. See also explaining filler firmness to the patient.
How to check the ANVISA registration?
If the patient wants to verify, guide them: the registration number appears on the label or the package insert, and can be looked up on ANVISA's official website, in the health products search area. See the official portal at gov.br/anvisa. It is also worth checking the invoice and the supplier's provenance. Be wary of a product with no label in Portuguese, no visible batch or of informal origin.
What about traceability?
Recording the batch is not a bureaucratic detail. In case of a complication, an unexpected reaction or a recall, the batch is what lets you identify what was used and act. Note in the patient record, for each procedure: product, manufacturer, batch, expiration date, amount, area and date. This record also protects you. See recording the complication in the patient record and patient record retention.
What might the patient mix up?
Two common mix-ups: thinking that an "expensive brand" means a "better result" and thinking that the product alone determines the result. The result depends on the indication, anatomy, technique, volume and each person's response. This conversation connects with explaining how long results last without promising and is this safe.
What to record?
Record the patient's question, what was shared (type, product, registration, batch), what was shown (packaging, label) and the criteria explained. If there was a brand preference and whether you accepted it or not, note it. Also record the batch and expiration date used. This demonstrates transparency and gives clinical and legal security.
Frequently asked questions
Does the patient have the right to know which product will be used?
Yes. Telling the patient the product, registration and batch is part of transparency and informed consent. The patient may ask, and you should answer clearly.
What should I record about the product in the patient record?
Product name, manufacturer, batch number, expiration date, amount used, area and date. This ensures traceability in case of a complication or a recall.
How do I check whether the product is registered with ANVISA?
Look up the registration number in the product search on ANVISA's official website (Brazil's health regulatory agency) and check the label and the invoice. Be wary of products with no registration or no provenance.
Can the patient choose the brand?
They can state a preference, but the technical choice belongs to the professional, based on the indication, the area and safety. Explain the criteria without turning the conversation into a brand dispute.
Harmy images are illustrative simulations generated by AI from the patient's photo to support the conversation between practitioner and patient. They are not a promise of results. Indication, technique, product and volume are solely the decision of the licensed practitioner. This content is for information only and does not replace a clinical assessment.